HK Recently Listed Stocks Watch | METIS TECHBIO-P (07666.HK) H1 Revenue Up 13,399% YoY, 110.4150 Million Cornerstone Lock-up Shares to Be Released on November 13

NewTimeSpace News, October 8, 2026: METIS TECHBIO-P (07666.HK) traded weaker, quoting HKD 16.06 as of 14:50, down 4.74%.

On the news front, according to prior disclosures, the 18 cornerstone investors hold in aggregate 110.4150 million H shares, with lock-up periods all running to November 12, 2026 and formal release starting from November 13, 2026, corresponding to a market value of approximately HKD 1.159 billion based on the offer price. The cornerstone lineup includes BlackRock, Mirae Asset, HHLRA, Deerfield and RTW fund, among others.

According to public information, METIS TECHBIO-P (07666.HK) listed on the Main Board of the Stock Exchange of Hong Kong on May 13, 2026 at an offer price of HKD 10.50, with a global offering of approximately 201 million H shares; gross proceeds were approximately HKD 2.113 billion and net proceeds approximately HKD 1.993 billion; the Hong Kong public offering was 6,910.96x subscribed and the international offering 33.86x subscribed.

On performance, the company disclosed its first interim results after listing on August 25, 2026: for the first half of 2026 it recorded operating revenue of RMB 154 million, up 13,399% year on year, and an adjusted net loss of RMB 51.10 million, narrowed 56.4% year on year.

SHENWAN HONGYUAN said that METIS TECHBIO-P enters the nano-delivery field with artificial intelligence; its AiLNP platform is the world's first and only AI-driven platform able to use a lipid language model to predict lipid and LNP properties; leveraging its NanoForge platform, the company has built four core solutions—AiTEM, AiLNP, AiRNA and AiProtein—and established more than 30 partnerships through a platform-plus-product dual-engine model.

METIS TECHBIO-P (07666.HK), founded in 2020, is an AI-driven nanomaterials innovation biotechnology company focused on the delivery and application of payloads in living organisms.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.